» Articles » PMID: 33882858

Risk Factors for Pediatric Surgical Site Infection Following Neurosurgical Procedures for Hydrocephalus: a Retrospective Single-center Cohort Study

Overview
Journal BMC Anesthesiol
Publisher Biomed Central
Specialty Anesthesiology
Date 2021 Apr 22
PMID 33882858
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Infection is a major complication following cerebral spinal fluid (CSF) diversion procedures for hydrocephalus. However, pediatric risk factors for surgical site infection (SSI) are currently not well defined. Because a SSI prevention bundle is increasingly introduced, the purpose of this study was to evaluate risk factors associated with SSIs following CSF diversion surgeries following a SSI bundle at a single quaternary care pediatric hospital.

Methods: We performed a retrospective cohort study of patients undergoing CSF diversion procedures from 2017 to 2019. SSIs were identified prospectively through continuous surveillance. We performed unadjusted logistic regression analyses and univariate analyses to determine an association between SSIs and patient demographics, comorbidities and perioperative factors to identify independent risk factors for SSI.

Results: We identified a total of 558 CSF diversion procedures with an overall SSI rate of 3.4%. The SSI rates for shunt, external ventricular drain (EVD) placement, and endoscopic third ventriculostomy (ETV) were 4.3, 6.9 and 0%, respectively. Among 323 shunt operations, receipt of clindamycin as perioperative prophylaxis and presence of cardiac disease were significantly associated with SSI (O.R. 4.99, 95% C.I. 1.27-19.70, p = 0.02 for the former, and O.R. 7.19, 95% C.I. 1.35-38.35, p = 0.02 for the latter). No risk factors for SSI were identified among 72 EVD procedures.

Conclusion: We identified receipt of clindamycin as perioperative prophylaxis and the presence of cardiac disease as risk factors for SSI in shunt procedures. Cefazolin is recommended as a standard antibiotic for perioperative prophylaxis. Knowing that unsubstantiated beta-lactam allergy label is a significant medical problem, efforts should be made to clarify beta-lactam allergy status to maximize the number of patients who can receive cefazolin for prophylaxis before shunt placement. Further research is needed to elucidate the mechanism by which cardiac disease may increase SSI risk after shunt procedures.

Citing Articles

Neurosurgical site infections: a retrospective monocentric study of pediatric brain tumor patients.

Enrico G, Fusco E, Palmetti M, Mussa F, Sardi I, Chiappini E Childs Nerv Syst. 2025; 41(1):120.

PMID: 39994029 PMC: 11850419. DOI: 10.1007/s00381-025-06765-w.


Effectiveness of subgaleal topical vancomycin powder in reducing infection rates and shunt revisions in pediatric ventriculoperitoneal shunt surgery: a promising prophylactic approach.

Uysal E, Cine H, Cakaloglu H Childs Nerv Syst. 2024; 41(1):3.

PMID: 39589542 DOI: 10.1007/s00381-024-06672-6.


Antibiotics in anesthesia and critical care.

Premachandra A, Moine P Ann Transl Med. 2024; 12(1):6.

PMID: 38304898 PMC: 10777233. DOI: 10.21037/atm-22-5585.


Healthcare-Associated Ventriculitis in Children during COVID-19 Pandemic: Clinical Characteristics and Outcome of a First Infection.

Licona-Enriquez J, Labra-Zamora M, Ramirez-Reyes A, Miranda-Novales M Antibiotics (Basel). 2023; 12(10).

PMID: 37887202 PMC: 10604527. DOI: 10.3390/antibiotics12101501.


Antibacterial Designs for Implantable Medical Devices: Evolutions and Challenges.

Cao H, Qiao S, Qin H, Jandt K J Funct Biomater. 2022; 13(3).

PMID: 35893454 PMC: 9326756. DOI: 10.3390/jfb13030086.


References
1.
Bruinsma N, Stobberingh E, Herpers M, Vles J, Weber B, Gavilanes D . Subcutaneous ventricular catheter reservoir and ventriculoperitoneal drain-related infections in preterm infants and young children. Clin Microbiol Infect. 2001; 6(4):202-6. DOI: 10.1046/j.1469-0691.2000.00052.x. View

2.
Yuki K, Murakami N . Sepsis pathophysiology and anesthetic consideration. Cardiovasc Hematol Disord Drug Targets. 2015; 15(1):57-69. PMC: 4704087. DOI: 10.2174/1871529x15666150108114810. View

3.
Kontny U, Hofling B, Gutjahr P, VOTH D, Schwarz M, Schmitt H . CSF shunt infections in children. Infection. 1993; 21(2):89-92. DOI: 10.1007/BF01710738. View

4.
Zaben M, Manivannan S, Sharouf F, Hammad A, Patel C, Bhatti I . The efficacy of endoscopic third ventriculostomy in children 1 year of age or younger: A systematic review and meta-analysis. Eur J Paediatr Neurol. 2020; 26:7-14. DOI: 10.1016/j.ejpn.2020.02.011. View

5.
Parker S, McGirt M, Murphy J, Megerian J, Stout M, Engelhart L . Comparative effectiveness of antibiotic-impregnated shunt catheters in the treatment of adult and pediatric hydrocephalus: analysis of 12,589 consecutive cases from 287 US hospital systems. J Neurosurg. 2014; 122(2):443-8. DOI: 10.3171/2014.10.JNS13395. View